These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1685521)

  • 21. Oral mexiletine in the treatment of refractory ventricular arrhythmias: the role of electrophysiologic techniques.
    Schoenfeld MH; Whitford E; McGovern B; Garan H; Ruskin JN
    Am Heart J; 1984 May; 107(5 Pt 2):1071-8. PubMed ID: 6372423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different electrophysiological effects of the levo- and dextro-rotatory isomers of mexiletine in isolated rabbit cardiac muscle.
    Gurabi Z; Patocskai B; Györe B; Virág L; Mátyus P; Papp JG; Varró A; Koncz I
    Can J Physiol Pharmacol; 2017 Jul; 95(7):830-836. PubMed ID: 28226224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of mexiletine enantiomers in healthy human subjects. A study of the in vivo serum protein binding, salivary excretion and red blood cell distribution of the enantiomers.
    Kwok DW; Kerr CR; McErlane KM
    Xenobiotica; 1995 Nov; 25(10):1127-42. PubMed ID: 8578769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liquid chromatographic resolution of mexiletine and its analogs on crown ether-based chiral stationary phases.
    Jin KB; Kim HE; Hyun MH
    Chirality; 2014 May; 26(5):272-8. PubMed ID: 24677299
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity.
    Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A
    J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective comparison of class IA, B, and C antiarrhythmic agents in combination with amiodarone in patients with inducible, sustained ventricular tachycardia.
    Toivonen L; Kadish A; Morady F
    Circulation; 1991 Jul; 84(1):101-8. PubMed ID: 1905591
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereoselective disposition of mexiletine in man.
    Grech-Belanger O; Turgeon J; Gilbert M
    Br J Clin Pharmacol; 1986 May; 21(5):481-7. PubMed ID: 3718807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective analysis of the enantiomers of mexiletine by high-performance liquid chromatography using fluorescence detection and study of their stereoselective disposition in man.
    McErlane KM; Igwemezie L; Kerr CR
    J Chromatogr; 1987 Apr; 415(2):335-46. PubMed ID: 3584372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias].
    Rolli A; Bonatti V; Finardi A; Favaro L; Botti G
    G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mexiletine in refractory ventricular arrhythmias.
    Fenster PE; Kern KB
    Clin Pharmacol Ther; 1983 Dec; 34(6):777-84. PubMed ID: 6641093
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.
    Pugsley MK; Saint DA; Penz MP; Walker MJ
    Br J Pharmacol; 1993 Dec; 110(4):1579-85. PubMed ID: 8306104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue distribution of mexiletine enantiomers in rats.
    Igwemezie L; Beatch GN; Walker MJ; McErlane KM
    Xenobiotica; 1991 Sep; 21(9):1153-8. PubMed ID: 1788983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of bepridil, verapamil, and quinidine in the prevention of ventricular tachycardia induced by programmed electrical stimulation in the digitalized dog.
    Keren G; Tepper D; Butler B; Torres V; Somberg JC
    Am Heart J; 1984 Nov; 108(5):1236-43. PubMed ID: 6333809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
    Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pharmacokinetics of the enantiomers of mexiletine in humans.
    Igwemezie L; Kerr CR; McErlane KM
    Xenobiotica; 1989 Jun; 19(6):677-82. PubMed ID: 2763576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of combination drug therapy with a class IC antiarrhythmic agent and mexiletine for ventricular tachycardia.
    Mendes L; Podrid PJ; Fuchs T; Franklin S
    J Am Coll Cardiol; 1991 May; 17(6):1396-402. PubMed ID: 2016457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Response of experimental ventricular tachycardia to class I anti-arrhythmia agents].
    de Micheli A; Medrano GA
    Arch Inst Cardiol Mex; 1992; 62(1):11-24. PubMed ID: 1562206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mexiletine in the treatment of lidocaine-resistant ventricular tachycardia. Preliminary results].
    Santinelli V; Chiariello M; Stanislao M; Turco P; Clarizia M; Condorelli M
    G Ital Cardiol; 1982; 12(6):457-9. PubMed ID: 7160572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mexiletine therapy for ventricular tachycardia.
    Maddox RW; Arnold WS
    South Med J; 1985 Apr; 78(4):482-3. PubMed ID: 3983671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of mexiletine on reperfusion-induced ventricular arrhythmias: comparison with lidocaine.
    Bonaduce D; Ferrara N; Abete P; Longobardi G; Leosco D; Canonico V; Morgano G; Rengo F
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):19-29. PubMed ID: 3827408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.